Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marco Liccari"'
Autor:
Ruggero Bacchin, Marco Liccari, Mauro Catalan, Lucia Antonutti, Paolo Manganotti, Maria Chiara Malaguti, Bruno Giometto
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 361-368 (2024)
Abstract Background Opicapone is a third-generation catechol-O-methyl-transferase inhibitor currently used for the treatment of motor fluctuations in Parkinson’s disease. Its benefit and safety have been established by clinical trials; however, dat
Externí odkaz:
https://doaj.org/article/610e1e94738f4123be7cd4f520815cf1
Autor:
Alberto Cucca, Claudia Virginia Manara, Mauro Catalan, Marco Liccari, Lucia Antonutti, Tiziana Maria Isabella Lombardo, Valentina Cenacchi, Sophie Rangan, Serena Mingolo, Carmelo Crisafulli, Franca Dore, Mauro Murgia, Tiziano Agostini, Paolo Manganotti
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
Visual hallucinations are prevalent, potentially disabling symptoms of Parkinson’s Disease. Multiple impairments in bottom-up sensory processing and top-down perceptual modulation are implicated in the pathophysiology of these phenomena. In healthy
Externí odkaz:
https://doaj.org/article/a71f89b708c04f8ca722846d11c4467f
Autor:
Roberta Bulla, Lucrezia Rossi, Giovanni Furlanis, Chiara Agostinis, Miriam Toffoli, Andrea Balduit, Alessandro Mangogna, Marco Liccari, Giorgia Morosini, Uday Kishore, Paolo Manganotti
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Brain fog can be described as a constellation of new-onset neuropsychiatric sequelae in the post-acute phase of COVID-19 (long COVID). The symptoms include inattention, short-term memory loss, and reduced mental acuity, which may undermine cognition,
Externí odkaz:
https://doaj.org/article/8687a22fb20f40cda14ad78abab53962